Clinical Trial Update: Thymoglobulin Induction in Kidney Transplant Recipients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating thymoglobulin induction in kidney transplant recipients; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury
• Kidney Transplantation

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: University of Oxford | Conditions: Kidney Transplantation, Ischemia-Reperfusion Injury | Phase 3 | Status: UNKNOWN